LEADER 03331nam  2200565Ia 450 
001 9910451851303321
005 20200520144314.0
035   $a(CKB)1000000000450676
035   $a(EBL)3377519
035   $a(SSID)ssj0000266428
035   $a(PQKBManifestationID)11225170
035   $a(PQKBTitleCode)TC0000266428
035   $a(PQKBWorkID)10305639
035   $a(PQKB)11397546
035   $a(MiAaPQ)EBC3377519
035   $a(Au-PeEL)EBL3377519
035   $a(CaPaEBR)ebr10071561
035   $a(OCoLC)923271148
035   $a(EXLCZ)991000000000450676
100   $a20050321d1996      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aVaccines against malaria$b[electronic resource] $ehope in a gathering storm /$fCommittee on Malaria Vaccines, Board on International Health, Board on Health Promotion and Disease Prevention, Institute of Medicine ; Philip K. Russell and Christopher P. Howson, editors
210   $aWashington, D.C. $cNational Academy Press$d1996
215   $a1 online resource (40 p.)
300   $aDescription based upon print version of record.
311   $a0-309-57150-2 
320   $aIncludes bibliographical references.
327   $a""Vaccines Against Malaria: Hope in a Gathering Storm""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""1 Summary""; ""PROJECT CHARGE""; ""ORGANIZATION OF THE REPORT""; ""FINDINGS AND RECOMMENDATIONS""; ""Findings""; ""Recommendations""; ""2 Malaria: The Deteriorating Situation""; ""GLOBAL EXTENT, CAUSATIVE AGENT, AND MODE OF TRANSMISSION OF MALARIA""; ""Life-Threatening Complications of Malaria""; ""HEALTH IMPACT OF MALARIA ON THE U.S. POPULATION""; ""U.S. Travelers Abroad""; ""U.S. Resident Population""; ""ECONOMIC AND DEVELOPMENT IMPACT OF MALARIA""
327   $a""CURRENT STRATEGIES FOR MALARIA CONTROL""""Drug-Based Control Strategies""; ""Vector-Based Control Strategies""; ""THE RATIONALE FOR DEVELOPING A MALARIA VACCINE""; ""GOALS AND TARGET POPULATIONS FOR MALARIA VACCINES""; ""Preerythrocytic Vaccines""; ""Asexual Blood-Stage Vaccines""; ""Sexual (Gametocyte) Vaccines""; ""3 Malaria Vaccines: The Elements for Success Are Moving into Place""; ""4 Current Obstacles to Development""; ""THE SCIENCE""; ""COORDINATION""; ""5 Solutions for Science""; ""6 Solutions for Coordination""; ""PREREQUISITES FOR SUCCESS""
327   $a""MODELS FOR COORDINATION AND LEADERSHIP""""IMPLEMENTING COORDINATION""; ""Initial Considerations""; ""Prioritization, Product Development, and Process Management""; ""Initial Efforts to Coordinate Malaria Vaccine R&D""; ""THE NEXT STEPS""; ""References""; ""Appendix Workshop Agenda""; ""AGENDA""; ""Summary of Agency Activities""
606   $aMalaria vaccine$vCongresses
606   $aMalaria$zUnited States$xPrevention$vCongresses
608   $aElectronic books.
615  0$aMalaria vaccine
615  0$aMalaria$xPrevention
676   $a616.9362079
701   $aRussell$b Philip K$0888133
701   $aHowson$b Christopher Paul$0862972
712 02$aInstitute of Medicine (U.S.).$bCommittee on Malaria Vaccines.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910451851303321
996   $aVaccines against malaria$91983769
997   $aUNINA